-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
Genomic landscape of malignant peripheral nerve sheath tumor (MPNST)
Study
EGAS00001006069
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
Molecular and functional profiling of plasmablastic lymphoma
Study
EGAS00001004659
-
Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study
Study
EGAS00001004664
-
Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial
Study
EGAS00001006073
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Study
EGAS00001005617
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
A novel orthotopic patient-derived xenograft model of radiation-induced glioma following medulloblastoma
Study
EGAS00001004709
-
STAT5 is a therapeutically targetable vulnerability in cutaneous T-cell lymphoma
Study
EGAS00001004719
-
Multiomics Characterization of Low-grade Serous Ovarian Carcinoma
Study
EGAS00001004724
-
Microbiota 16S sequencing study in NSCLC patients eligible for surgery without neoadjuvant treatment
Study
EGAS00001004728
-
USARC 10X Genomics Single Cell DNA Sequencing Data
Study
EGAS00001006144
-
Multi-region whole-exome sequencing of 10 neuroblastoma cases
Study
EGAS00001004735
-
Summary statistics from genome-wide association study in glioma of 12,488 cases and 18,169 controls.
Study
EGAS00001003372
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
Discriminating Th17.1 cell driven sarcoidosis-like inflammation from relapse after anti-BCMA CAR T cells in multiple myeloma
Study
EGAS00001006133
-
Overactivation of the IGF signalling pathway in osteosarcoma
Study
EGAS00001004767
-
FACS sorting of ploidy populations in an undifferentiated soft tissue sarcoma for RRBS
Study
EGAS00001006143
-
DNA and RNA sequencing data from Ovarian Carcinosarcoma patients from the Glasgow Cohort.
Study
EGAS00001006605
-
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
Study
EGAS00001003408
-
RNA sequencing of multiple myeloma identifies genes dysregulated by structural variants.
Study
EGAS00001003411
-
Neuroblastoma tumor heterogeneity and cell plasticity (from PDX and cell lines)
Study
EGAS00001004781
-
Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient
Study
EGAS00001004857
-
Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study
Study
EGAS00001006191
-
Failure of Differentiation of the Rhombic Lip Constitutes Medulloblastoma
Study
EGAS00001005826
-
Genomic analysis of a hypermutated gliosarcoma
Study
EGAS00001004864
-
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas
Study
EGAS00001003430
-
Gut microbiome sequencing in patients receiving combination immune checkpoint blockade
Study
EGAS00001004885
-
Single_cell_characterization_of_T_cell_lymphoma_
Study
EGAS00001005750
-
Multi-region exome sequencing of lung adenocarcinoma precursors -1
Study
EGAS00001003439
-
Paired data of primary and relapse central nervous system lymphoma and testicular lymphoma
Study
EGAS00001005833
-
Clinical impact of immune checkpoint inhibitor (ICI) response, DNA damage repair (DDR) gene mutations and immune-cell infiltration in subtypes of metastatic melanoma
Study
EGAS00001005781
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
Study
EGAS00001003447
-
Single-cell RNA sequencing on single CD45+ immune cells isolated from peripheral blood, lymphnode, ascites, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001003449
-
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Study
EGAS00001006196
-
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Study
EGAS00001006200
-
glioblastoma single cell RNAseq
Study
EGAS00001006236
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
Combined gene expression and digital pathology identifies molecular mediators of T cell exclusion and immune suppression in ovarian cancer
Study
EGAS00001003487
-
Epithelioid sarcoma sequencing data
Study
EGAS00001005983
-
Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
Study
EGAS00001003497
-
Application of high-throughput, high-depth, targeted single-nucleus DNA sequencing in pancreatic cancer
Study
EGAS00001006024
-
Single cell analyses of transcriptome and epigenome in neuroblastoma infiltrated bone marrow
Study
EGAS00001006106
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
Single cell multi-omic data of glioblastoma evolution under therapy
Study
EGAS00001004909
-
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Study
EGAS00001006293
-
MGP Panel: a comprehensive targeted genomics panel for molecular profiling of multiple myeloma patients
Study
EGAS00001006222
-
Melanoma_post_mortem_analysis
Study
EGAS00001003531
-
Whole exome-sequencing of pediatric and adult H3-K27M diffuse midline glioma
Study
EGAS00001006431
-
Longitudinal ctDNA in Uveal Melanoma
Study
EGAS00001006373
-
OAC WGS
Study
EGAS00001006470
-
Combination of CDK4/6 with BET-bromodomain and PI3K/mTOR inhibitors in medulloblastoma in vitro and in vivo
Study
EGAS00001006286
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001006306
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma___2
Study
EGAS00001003542
-
Diffuse Intrinsic Pontine Glioma
Study
EGAS00001006353
-
Placebo-only arm transcriptomic analysis of the phase 3 PROTECT clinical trial
Study
EGAS00001006344
-
Clonal dominance defines metastatic dissemination in pancreatic cancer
Study
EGAS00001006358
-
Brain tumor sequencing data
Study
EGAS00001006352
-
Glioma sequencing data
Study
EGAS00001006355
-
Combined targeting of BRD4-associated Promoter Activation and NFKB Immunomodulation in ARID1A-mutated Gastric Adenocarcinoma
Study
EGAS00001006397
-
Genomic landscape and molecularly-informed therapy in thymic carcinoma and other advanced thymic epithelial tumors (H021, HIPO)
Study
EGAS00001006408
-
Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data
Study
EGAS00001006388
-
DLP+ Single Cell Genomic Library A98288
Dataset
EGAD00001010247
-
Proteogenomics reveals two distinct biological pilocytic astrocytoma subgroups
Study
EGAS00001006402
-
High-resolution lung adenocarcinoma expression subtypes identify tumors with dependencies on MET, CDK4, CDK6, and PD-L1
Study
EGAS00001006461
-
Dedifferentiated_Melanoma_RNAseq
Study
EGAS00001003601
-
in silico drug target prediction for melanoma
Study
EGAS00001006463
-
Repurposing azacitidine and carboplatin to prime immune checkpoint blockade-resistant melanoma for anti-PD-L1 re-challenge
Study
EGAS00001006419
-
Repurposing azacitidine and carboplatin to prime immune checkpoint blockade-resistant melanoma for anti-PD-L1 re-challenge
Study
EGAS00001006420
-
ctDNA quantification in Ewing sarcoma patients
Study
EGAS00001006433
-
T cell reactivity of MHC epitopes
Study
EGAS00001006445
-
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Study
EGAS00001003672
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Whole Transcriptome Sequencing
Study
EGAS00001006528
-
Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA-sequencing the pros and cons
Study
EGAS00001006535
-
OAC RNASeq
Study
EGAS00001006468
-
OAC scRNASeq
Study
EGAS00001006469
-
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon-based sequencing
Study
EGAS00001004941
-
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma
Study
EGAS00001003746
-
SPECIAL: Dissecting the melanoma ecosystem one cell at the time during immunotherapy
Study
EGAS00001006488
-
Colorectal cancer study
Study
EGAS00001006489
-
Immune microenvironment and lineage tracing help deciphering Rosette-forming GlioNeuronal Tumors: a multi-omic analysis of 9 cases
Study
EGAS00001006502
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Exome Sequencing
Study
EGAS00001006529
-
Neuroblastoma Evolution
Study
EGAS00001006533
-
Single-cell multi-omics of relapse/refractory multiple myeloma patients (Hipo K08K/H067/K43R)
Study
EGAS00001006538
-
Significant and pervasive effects of RNA degradation on Nanopore direct RNA sequencing
Study
EGAS00001006542
-
Immuno-genomic landscape of osteosarcoma
Study
EGAS00001003887
-
A living biobank of patient-derived ductal carcinoma in situ Mouse-INtraDuctal xenografts identifies factors associated with risk of invasive progression
Study
EGAS00001006554
-
Genomic and epigenomic study of Japanese renal cell carcinoma including WGS, RNA-seq, ATAC-seq, and methyl-seq
Study
EGAS00001006919
-
DERMATLAS__Tubular_adenoma
Study
EGAS00001006686
-
Long-read sequencing for cell-free DNA analysis (human pacbio)
Study
EGAS00001006609
-
Uncovering tumor intrinsic and extrinsic factors that regulate hepatocellular carcinoma growth using patient derived xenograft assays
Study
EGAS00001004020
-
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models: validation cohort
Study
EGAS00001006582
-
Whole-Transcriptomic Profiling of Sorted Human Renal Cell Carcinoma Immune Populations
Study
EGAS00001006593
-
Genomic_characterisation_of_MGUS__
Study
EGAS00001004124
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC-- CA209-025
Study
EGAS00001004292